Arcus Biosciences Inc (NYSE:RCUS)
$ 15.27 -0.56 (-3.54%) Market Cap: 1.40 Bil Enterprise Value: 417.63 Mil PE Ratio: 0 PB Ratio: 2.47 GF Score: 79/100

Q1 2024 Arcus Biosciences Inc Earnings Call Transcript

May 08, 2024 / 08:30PM GMT
Release Date Price: $15.26 (-1.93%)
Operator

Hello all and welcome to the Arcus Biosciences' first-quarter 2024 earnings call. My name is Lydia, and I'll be your operator today. (Operator Instructions)

I'll now hand you over to Pia Eaves, Vice President of Investor Relations.

Pia Eaves
Arcus Biosciences Inc - Vice President, Investor Relations

Hello, everyone, and thank you for joining us on today's conference call to discuss Arcus's first-quarter 2024 financial results and pipeline update. I'd like to remind you that on this call, management will make forward-looking statements, including statements about our cash runway and our expected clinical development milestones and timelines.

All statements other than historical facts reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those. Those risks and uncertainties are described in our annual report on Form 10-K and quarterly report on Form 10-Q, which have been filed with the SEC. We strongly encourage you to review our filings.

Today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot